Roots of Clinical Resistance to STI-571 Cancer Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Roots of Clinical Resistance to STI-571 Cancer Therapy

Published:2001-09-21 Issue:5538 Volume:293 Page:2163-2163
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Barthe Christophe¹,Cony-Makhoul Pascale²,Melo Junia V.³,Mahon Josy Reiffers François-Xavier⁴

Affiliation:

1. Laboratoire Greffe de Moelle Université Victor Segalen Bordeaux, France

2. Service des Maladies du Sang Centre Hospitalier Universitaire de Bordeaux Bordeaux, France

3. Department of Haematology Imperial College School of Medicine Hammersmith Hospital Ducane Road London W12 0NN, UK E-mail:

4. Laboratoire Greffe de Moelle Université Victor Segalen and Service des Maladies du Sang Centre Hospitalier Universitaire de Bordeaux

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference29 articles.

1. Efficacy and Safety of a Specific Inhibitor of the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia

2. Druker B. J., et al., N. Engl. J. Med. 344, 1038 (2001).

3. Clinical Resistance to STI-571 Cancer Therapy Caused by BCR-ABL Gene Mutation or Amplification

4. ; published online 21 June 2001 (10.1126/science.1062538).

5. le Coutre P., et al., Blood 95, 1758 (2000).

Cited by 194 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Forward Genetic Screens Identify Mechanisms of Resistance to Small-Molecule Lactate Dehydrogenase Inhibitors;ACS Chemical Biology;2024-01-25

2. Forward genetic screens identify mechanisms of resistance to small molecule lactate dehydrogenase inhibitors;2023-09-30

3. Characterization of the cholangiocarcinoma drug pemigatinib against FGFR gatekeeper mutants;Communications Chemistry;2022-08-22

4. The Oncogenic Protein, Breakpoint Cluster (BCR)-Abelson Kinase (ABL) and Chronic Myelocytic Leukemia (CML): Insight Into the Drug Resistance Mechanisms and Approaches for Targeting BCR-ABL in CML;Reference Module in Biomedical Sciences;2021

5. LncRNA MEG3 Regulates Imatinib Resistance in Chronic Myeloid Leukemia via Suppressing MicroRNA-21;Biomolecules & Therapeutics;2017-09-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3